Gapping up
In reaction to earnings/guidance:
- PAGS +6.2%, BLNK +5.9%, CODX +5.8%, SFT +5.2%, PHUN +3.1%, SPB +2.1%, AVIR +1.7%, AQN +1.7%, FLO +1%, RYAN +0.9%, OPNT +0.8%
Other news:
- FTCH +11.8% (confirms discussions with Richemont to expand partnership)
- VIR +4.8% (reports primary endpoint met in COMET-TAIL Phase 3 trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19)
- TERN +4.8% (highlights positive clinical data from multiple NASH Programs)
- TIGO +4.2% (to acquire full control of Tigo Guatemala)
- APLS +3.9% (reiterates plans to submit a new drug application in the first half of 2022 for Pegcetacoplan for geographic atrophy following FDA feedback)
- AGEN +3.1% (Clinical Activity of AGEN1181 Demonstrated Across Nine Treatment-Resistant Cancers at SITC)
- JNJ +3% (confirms plans to separate consumer health business)
- ACHL +2.9% (Presents Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting Demonstrating the Ability to Detect, Quantify and Track Patient-specific cNeT and Significant Increase in cNeT Dose from VELOS Process 2 Manufacturing)
- BIIB +2.6% (phase 3 data show positive correlation between ADUHELM and decline in Alzheimer's)
- ESPR +2.6% (Presents Important New Science Highlighting Potential Benefits of NEXLETOL)
- ADAP +2.1% (reports translational data at SITC 2021 from Adaptimmune's Phase 1 SURPASS Trial Indicate Adding AKTi)
- BKSY +1.9% (secured a five-year, sole-source blanket purchase agreement by the NASA to provide high revisit satellite imaging data in support of the agency's existing Earth observation research to advance predictive capabilities)
- EBS +1.6% (authorizes $250 mln share repurchase program)
- TM +1.4% (announces that global production plan in December is expected to reach the 800,000 units level including the recovery from the impact of the previous production cutbacks )
- DDD +1.3% (prices offering of $400.0 mln of 0% convertible senior notes due 2026)
- BLDP +1.1% (acquires Arcola Energy)
- SPOT +0.8% (to acquire Findaway, a leader in digital audiobook distribution)
Analyst comments:
- CGNX +1% (upgraded to Equal-Weight from Underweight at Morgan Stanley)